|
Q1 FY2027
As of Sep 30, 2026
|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
|
|---|---|---|---|
| Cash and cash equivalents | |||
| Total current assets | |||
| TOTAL ASSETS | |||
| Accrued expenses | |||
| Other payable | |||
| Amount due to (from) a director | |||
| Total current liabilities | |||
| Total Liabilities | |||
| Common stock, $0.001 par value; 10,330,730 shares issued and outstanding | |||
| Additional paid-in-capital | |||
| Accumulated deficit | |||
| Total Stockholders’ Equity | |||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...